Skip to main content

Table 2 Hepatic FA compositions at the end of week 26

From: A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet

Ingredient (ng/mg liver)

Control chow

CDAA-HF-T(+)

CDAA-HF-T(−)

C14:0

120 ± 21

1131 ± 192 a

1021 ± 140 a

C16:0

5423 ± 715

27,503 ± 4477 a

30,389 ± 5932 a

C16:1n-7

933 ± 268

4856 ± 1258 a

4165 ± 587 a

C18:0

1984 ± 417

3671 ± 291 a

4479 ± 1021 a

C18:1n-7

830 ± 207

10,380 ± 1441 a

4237 ± 414 a

C18:1n-7 t

16 ± 5

2246 ± 315 a

96 ± 15 a, +

C18:1n-9

4860 ± 898

66,045 ± 12,407 a

83,732 ± 19,926 a

C18:1n-9 t

13 ± 7

1647 ± 156 a

155 ± 44 +

C18:2n-6

7692 ± 1247

35,212 ± 1832 a

33,790 ± 8871 a

C18:2n-6tt

N.D.

901 ± 63

22 ± 7

C18:3n-3

177 ± 55

154 ± 20

124 ± 40

C18:3n-6

50 ± 32

1393 ± 157 a

2517 ± 73 a, +

C20:0

51 ± 22

169 ± 16 a

224 ± 51 a

C20:2n-6

67 ± 11

433 ± 56 a

354 ± 52 a

C20:3n-6

443 ± 62

1404 ± 89 a

2158 ± 470 a, +

C20:4n-6

2889 ± 434

8668 ± 775 a

12,602 ± 3034 a, +

C20:5n-3

400 ± 91

11 ± 1 a

27 ± 13 a

C22:5n-3

148 ± 26

178 ± 17

219 ± 47 a

C22:6n-3

8754 ± 15

2930 ± 476 a

4184 ± 1178 a

Total

34,850 ± 4687

168,925 ± 20,918 a

184,484 ± 41,347 a

  1. Values are presented as the mean ± SD (n = 4).
  2. Significantly different from the values of acontrol chow or +CDAA-HF-T(+) groups.
  3. N.D. Not detected.